136 related articles for article (PubMed ID: 7647217)
1. Tissue factor expression in endothelial cells in health and disease.
Wada H; Wakita Y; Shiku H
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S26-31. PubMed ID: 7647217
[TBL] [Abstract][Full Text] [Related]
2. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
3. miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulation.
Zhang R; Lu S; Yang X; Li M; Jia H; Liao J; Jing Q; Wu Y; Wang H; Xiao F; Bai X; Na X; Kang Y; Wan L; Yang J
Biochem Pharmacol; 2021 Oct; 192():114671. PubMed ID: 34246626
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
[TBL] [Abstract][Full Text] [Related]
5. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
[TBL] [Abstract][Full Text] [Related]
6. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin.
Roth RI
Blood; 1994 May; 83(10):2860-5. PubMed ID: 8180381
[TBL] [Abstract][Full Text] [Related]
9. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation.
Wada H; Nakase T; Nakaya R; Minamikawa K; Wakita Y; Kaneko T; Ohiwa M; Deguchi K; Shirakawa S
Am J Hematol; 1994 Mar; 45(3):232-6. PubMed ID: 8296794
[TBL] [Abstract][Full Text] [Related]
11. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells.
Key NS; Bach RR; Vercellotti GM; Moldow CF
Lab Invest; 1993 Jun; 68(6):645-51. PubMed ID: 8390591
[TBL] [Abstract][Full Text] [Related]
13. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
[TBL] [Abstract][Full Text] [Related]
14. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation.
Kobayashi K; Baba K; Igase M; Miyama TS; Kambayashi S; Okuda M
J Vet Med Sci; 2020 Jan; 82(1):56-60. PubMed ID: 31787663
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tissue factor and cytokine release.
Gray E; Thomas S; Mistry Y; Poole S
Haemostasis; 1996; 26 Suppl 1():92-5. PubMed ID: 8904180
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.
Cermak J; Key NS; Bach RR; Balla J; Jacob HS; Vercellotti GM
Blood; 1993 Jul; 82(2):513-20. PubMed ID: 8329706
[TBL] [Abstract][Full Text] [Related]
17. Scoparone inhibits tissue factor expression in lipopolysaccharide-activated human umbilical vein endothelial cells.
Lee YM; Hsiao G; Chang JW; Sheu JR; Yen MH
J Biomed Sci; 2003; 10(5):518-25. PubMed ID: 12928592
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood.
Souter PJ; Thomas S; Hubbard AR; Poole S; Römisch J; Gray E
Crit Care Med; 2001 Jan; 29(1):134-9. PubMed ID: 11176173
[TBL] [Abstract][Full Text] [Related]
19. Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1β.
Kamegashira A; Yanase Y; Takahagi S; Saito R; Uchida K; Kawaguchi T; Ishii K; Tanaka A; Ozawa K; Hide M
J Dermatol; 2020 Nov; 47(11):1293-1300. PubMed ID: 32748974
[TBL] [Abstract][Full Text] [Related]
20. Production of tissue factor in CD14-expressing human umbilical vein endothelial cells by lipopolysaccharide.
Chakravortty D; Kato Y; Koide N; Sugiyama T; Kawai M; Fukada M; Yoshida T; Yokochi T
FEMS Microbiol Lett; 1999 Sep; 178(2):235-9. PubMed ID: 10499273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
